期刊文献+

先占性抗巨细胞病毒治疗影响艾滋病合并巨细胞病毒血症患者预后的临床研究 被引量:4

Clinical study on the effect of preemptive anti-cytomegalovirus therapy on prognosis of patients with acquired immunodeficiency syndrome and cytomegalovirus viraemia
原文传递
导出
摘要 目的 探讨先占性抗巨细胞病毒(CMV)治疗对艾滋病合并CMV血症患者预后的影响.方法 2011年7月1日至2013年6月30日住院的伴CMV血症的男性艾滋病患者共69例,按患者意愿,非随机对照分为2组,即治疗组(抗CMV组)57例、对照组(非抗CMV组)12例,治疗组采用更昔洛韦或膦甲酸钠静脉注射,CMV-DNA阴转后1周停药,3周末行抗高效逆转录病毒治疗(HAART);对照组仅行HAART及其他对症治疗,评价入组时两组CMV-DNA载量、HIV-RNA载量、CD4+T细胞计数、卡氏肺孢子菌肺炎(PCP)以及活动性结核的合并感染率有无差异.观察期12月,评价观察期末两组CD4+T细胞计数、CMV视网膜炎的发生率、再住院率以及死亡率的差异.结果 入组时两组CMV-DNA载量、HIV-RNA载量、CD4+T细胞计数差异无统计学意义(P>0.05);两组PCP、活动性结核的合并感染率差异无统计学意义(P>0.05).与对照组相比,抗CMV组12个月时CD4+T细胞计数及再住院率明显得到改善(t=-3.850,P<0.05;x2=6.078,P<0.05).观察期内两组均无CMV视网膜炎发生.两组死亡率差异无统计学意义(P>0.05).结论 先占性抗CMV治疗有利于艾滋病合并CMV血症患者的CD4+T细胞计数增长及减少再住院率,并阻止了CMV视网膜炎的发生,有利于细胞免疫重建及改善艾滋病患者的生存质量. Objective To explore the effect of preemptive anti-cytomegalovirus therapy on prognosis of patients with acquired immunodeficiency syndrome (AIDS) and cytomegalovirus (CMV) viraemia.Methods A non-random prospective study of male hospitalized patients were carried out who were newly diagnosed as AIDS during July 1,2011 to June 30,2013 in the First Affiliated Hospital of China Medical University.There were 69 patients who were divided into treatment group (57 cases) and control group (12cases).The duration of anti-cytomegalovirus therapy was a week after plasma CMV-DNA becoming undetectable.Baseline age,CMV-DNA,human immunodeficiency virus (HIV)-RNA,CD4+T cells,the rate of pneumocystis carinii pneumonia (PCP) and tuberculosis were evaluated between two groups.After 12-month follow-up,CD4 + T cells,the rate of rehospitalization,CMV retinitis,and mortality were evaluated.Results There were no difference in CMV-DNA,HIV-RNA,CD4 + T cells,the rate of PCP,and tuberculosis(P 〉 0.05).At the end of 12 months,there were higher CD4 +T cells and lower rehospitalization rate in treatment group than control group(t =-3.850,P 〈 0.05;x2 =6.078,P 〈 0.05).CMV retinitis was not found.The mortality was not different between two groups(P 〉0.05).Conclusions Anticytomegalovirus therapy was beneficial to the increment of CD4 +T cells and decrement of rehospitalization,and prevention from CMV retinitis.
出处 《中国医师杂志》 CAS 2015年第4期509-512,共4页 Journal of Chinese Physician
基金 辽宁省自然科学基金资助项目(2013021013)
关键词 巨细胞病毒感染/药物疗法 抗病毒药/治疗应用 获得性免疫缺陷综合征/并发症/治疗 病毒血症/并发症/治疗 预后 Cytomegalovirus infections/DT Antiviral agents/TU Acquired immunodeficiency syndrome/CO/TH Viremia/CO/TH Prognosis
  • 相关文献

参考文献18

  • 1王涛,陈平洋.先天性人巨细胞病毒感染防治研究进展[J].中国感染控制杂志,2009,8(4):294-296. 被引量:3
  • 2Gfiffiths PD. CMV as a cofactor enhancing progression of AIDS [J]. J Clin Virol ,2006 ,35 (4 ) :489-492.
  • 3Fielding K, Koba A, Grant AD, et al. Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV- infected gold miners in South Africa [ J]. PLoS One, 2011,6 (10) :e25571.
  • 4E1 Amari EB, Combescure C, Yerly S, et al. Clinical relevance of cytomegalovirus viraemia [ J ]. HIV Med, 2011,12 ( 7 ) : 394-402.
  • 5Foc E, Motta D, Pollara C, et al. Impact of detectable human ey- tomegalovirus DNAemia on viro-immunological effectiveness of HAART in HIV-infeeted patients naive to antiretroviral therapy [J]. New Mierobiol, 2012,35(2) :227-31.
  • 6Ying Wen, Pei L. Interferon successfully inhibited refractory cyto- megalovirus infection and resulted in CD4 + T-cells increase in a patient with AIDS [ J ] . HIV Clinical Trials, 2011, 12 ( 2 ) : 118- 120.
  • 7Hsu DC, Kerr SJ, Iampornsin T, et al. Restoration of CMV-Spe- cific-CD4 T Cells with ART Occurs Early and Is Greater in Those with More Advanced Immunodeficiency [ J ]. PLoS One, 2013,8 (10) : e77479.
  • 8Hunt PW, Martin JN, Sinclair E, et al. Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4 + T cell recovery on antiretroviral therapy[J]. J Infect Dis, 2011, 203(10) :1474-1483.
  • 9Shin LY, Sheth PM, Persad D, et al. Impact of CMV therapy with valganciclovir on immune activation and the HIV viral load in se- men and blood: an observational clinical study [ J ]. J Acquit Im- mune Defie Syndr, 2014,65(3) :251-258.
  • 10Jabs DA, Martin BK, Forman MS. Mortality associated with re- sistant cytomegalovirus among patients with cytomegalovirus reti- nitis and AIDS[ J]. Ophthalmology, 2010,117 ( 1 ) : 128-132.

二级参考文献10

  • 1谢臻蔚,金杭美.人巨细胞病毒先天性感染发病机制和产前诊断[J].国外医学(妇幼保健分册),2005,16(2):106-108. 被引量:2
  • 2陈细明,廖贤平.两种方案预防肾移植术后巨细胞病毒感染的临床观察[J].中国医师进修杂志,2006,29(12):17-18. 被引量:2
  • 3Griffiths PD. CMV as a cofactor enhancing progression of AIDS. J Clin Viro1,2006,35 (4) :489-492.
  • 4Fielding K, Koba A, Grant AD, et al. Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV- infected gold miners in South Africa. PLoS One, 2011,6(10): e25571.
  • 5E1 Amari EB, Combescure C, Yerly S, et 8]. Clinical relevance of cytomegalovirus viraemia. HIV Med, 2011,12 ( 7 ) : 394 -402.
  • 6Jabs DA, Martin BK, Forman MS. Mortality associated with resist- ant cytomegalovirus among patients with cytomegalovims retinitis and AIDS. Ophthalmology,2010,117( 1 ) :128-132.
  • 7Micol R, Buchy P, Guerrier G, et al. Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007). J Acquit Immune Defic Syndr,2009,51 (4) :486-491.
  • 8Jacobson M, Lurain N, Hunt P. Cytomegalovirus viraemia in the modern antiretroviral era( * ). HIV MOd, 2011,12(7) :387-388.
  • 9Mihlescu R, Arama V, Paraschiv S, et al. Impact of highly ac- tive anfiretroviral therapy on cytomegalovirus viraemia in the ab- sence of specific anti-cytomegalovirus therapy. Rom J Intern Med, 2008,46(4) :305-311.
  • 10荣丽英,刘晓军,李维超,陈净,郭静.巨细胞病毒感染新生儿及小婴儿的临床特征及免疫功能变化[J].实用儿科临床杂志,2008,23(22):1765-1767. 被引量:8

共引文献2

同被引文献30

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部